Quantcast

Latest Diabetic foot Stories

2011-07-24 00:02:04

TheraSkin® a biologically active real skin wound therapy, is now covered for Medicare Beneficiaries in Arkansas, Louisiana and Mississippi. Clinical results are excellent, and demonstrate the potential to save many Seniors from life-threatening lower limb amputations. Estimated to save healthcare in the US more than one billion dollars over next decade Newport News, VA (PRWEB) July 23, 2011 Soluble Systems, LLC announced today that Pinnacle Business Solutions, Inc., the Medicare Part A...

2011-07-05 00:00:30

TheraSkin® a biologically active real skin wound therapy, is now covered for Medicare Beneficiaries in Texas, thanks to decision by Trailblazer Health Enterprises. Clinical results are excellent, and demonstrate the potential to save many Seniors from life-threatening lower limb amputations. Estimated to save healthcare in the US more than one billion dollars over next decade. Newport News, VA (PRWEB) July 03, 2011 Soluble Systems, LLC announced today that Trailblazer Health...

2011-06-27 00:00:30

Pennsylvanians with Highmark Blue Cross/Blue Shield insurance are the first in the State to enjoy coverage for TheraSkin®, a biologically active real skin wound therapy that jumpstarts healing of non-performing wounds. TheraSkin® clinical results are excellent, and demonstrate the potential to save many diabetic patients from life-threatening lower limb amputations. TheraSkin® is a potent new weapon in the battle against rising healthcare costs, with potential to save patients...

2011-06-24 16:32:00

SAN DIEGO, June 24, 2011 /PRNewswire/ -- Advanced BioHealing, Inc. (ABH), a leader in commercializing living cell-therapies, a cornerstone technology in the field of regenerative medicine, today announced results from a health economics model developed by The Lewin Group (Falls Church, VA) that showed the addition of Dermagraft® to conventional care for the treatment of chronic diabetic foot ulcers (DFUs) resulted in a significant therapeutic and cost benefit compared to...

2011-06-02 08:00:00

FORT WORTH, Texas, June 2, 2011 /PRNewswire/ -- Healthpoint Biotherapeutics today announced that it has acquired Regranex® Gel, along with the corresponding intellectual property (including patents), from Systagenix. Terms of the deal were not disclosed. "This acquisition is aligned with our strategic focus on building a portfolio of novel biopharmaceuticals for wound healing and tissue regeneration," said Travis E. Baugh, President and Chief Operating Officer of...

2011-05-17 15:05:00

DUBLIN, May 17, 2011 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has signed an agreement to acquire Advanced BioHealing, Inc. - Creation of a new strategic platform based on tissue regeneration using cell-based therapies complements Shire's existing specialty focus and biologics manufacturing capability - Strong strategic fit with Shire - High medical need for symptomatic...

2011-04-27 10:06:00

ROSEMONT, Ill., April 27, 2011 /PRNewswire-USNewswire/ -- A recent study published in the March issue of Foot & Ankle International (FAI), the official scientific journal of the American Orthopaedic Foot & Ankle Society (AOFAS) describes a possible amputation alternative for patients with neuropathic ulceration of the first metatarsophalangeal (MTP) or big toe joint. The findings are noteworthy as diabetes is the leading cause for non-accident/injury leg and foot amputations...

2011-04-11 10:26:00

MARIETTA, Ga., April 11, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products and bioimplants processed from human amniotic membrane, announced today the nation-wide launch of the Company's latest product, EpiFix(TM), a biologic implant specifically processed to offer a wide variety of wound healing and wound care options. The Company also announces the hiring of Frank Burrows as its Vice...

2011-03-15 06:30:00

SAN DIEGO, March 15, 2011 /PRNewswire/ -- DJO Global, Inc. ("DJO" or the "Company"), a leading provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that one of its indirect subsidiaries has signed a definitive agreement to purchase Rikco International, LLC, D/B/A Dr. Comfort ("Dr. Comfort" or "DRC"), for approximately $254.6 million in cash. The transaction is expected to close within 30 - 45 days, subject to customary...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.